Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | CDC25A | P30304 | 1/20 | 0.46 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.46 |
| ▸ | AKT1 | P31749 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.43 |
| ▸ | GMNN | O75496 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | BLM | P54132 | 2/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2449830 | 1.00 | ALDH1A1 (0.56) | ALDH1A1MEN1KMT2AS1PR1LMNA | |
| SCHEMBL1117274 | 0.97 | ALDH1A1 (0.51) | ALDH1A1MEN1KMT2AS1PR1LMNA | |
| SCHEMBL10702628 | 0.93 | ALDH1A1 (0.56) | ALDH1A1MEN1KMT2AS1PR1LMNA | |
| SCHEMBL4619498 | 0.92 | ALDH1A1 (0.64) | ALDH1A1MEN1KMT2AS1PR1LMNA | |
| SCHEMBL479610 | 0.92 | ALDH1A1 (0.64) | ALDH1A1MEN1KMT2AS1PR1LMNA | |
| SCHEMBL4619726 | 0.92 | ALDH1A1 (0.64) | ALDH1A1MEN1KMT2AS1PR1LMNA | |
| SCHEMBL479563 | 0.92 | ALDH1A1 (0.64) | ALDH1A1MEN1KMT2AS1PR1LMNA | |
| SCHEMBL6120206 | 0.92 | ALDH1A1 (0.54) | ALDH1A1MEN1KMT2AS1PR1LMNA | |
| SCHEMBL1576782 | 0.91 | ALDH1A1 (0.66) | ALDH1A1MEN1KMT2AS1PR1LMNA | |
| SCHEMBL2561609 | 0.91 | ALDH1A1 (0.66) | ALDH1A1MEN1KMT2AS1PR1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023034901-A1 | TUMOR AVATAR VACCINE COMPOSITIONS AND USES THEREOF | THE BROAD INSTITUTE, INC. (US) | 2023-03-09 | — | — | WO | claimed |
| WO-2021071977-A1 | IN VITRO METHODS AND COMPOSITIONS FOR ENHANCING THE ACTIVATION OF DENDRITIC CELLS AND T CELLS, AND FOR INDUCING A TH-1 IMMUNE RESPONSE | NORTHWEST BIOTHERAPEUTICS, INC. (US) | 2021-04-15 | — | — | WO | claimed |
| EP-2691401-A1 | BIOMARKER-TARGETING CONTRAST AGENTS AND THEIR USE IN MAGNETIC RESONANCE IMAGING FOR DETECTION OF ATHEROSCLEROTIC PLAQUE | Luna Innovations Incorporated (US) | 2014-02-05 | — | — | EP | claimed |
| WO-2012135550-A1 | BIOMARKER-TARGETING CONTRAST AGENTS AND THEIR USE IN MAGNETIC RESONANCE IMAGING FOR DETECTION OF ATHEROSCLEROTIC PLAQUE | LUNA INNOVATIONS INCORPORATED (US) | 2012-10-04 | — | — | WO | claimed |
| EP-4337101-A1 | METHODS AND COMPOSITIONS FOR TREATING AGING AND CHRONIC DISEASE | L.E.A.F Holdings Group LLC (US) | 2024-03-20 | — | — | EP | disclosed |
| EP-4322999-A2 | HYPERACTIVATORS OF MAMMALIAN DENDRITIC CELLS | Corner Therapeutics, Inc. (US) | 2024-02-21 | — | — | EP | disclosed |
| WO-2023150758-A1 | HYPERACTIVATING LIPID NANOPARTICLES | CORNER THERAPEUTICS, INC. (US) | 2023-08-10 | — | — | WO | disclosed |
| EP-4185280-A1 | TRANS-CROCETIN COMPOSITIONS AND TREATMENT REGIMENS | L.E.A.F Holdings Group LLC (US) | 2023-05-31 | — | — | EP | disclosed |
| WO-2023034901-A1 | TUMOR AVATAR VACCINE COMPOSITIONS AND USES THEREOF | THE BROAD INSTITUTE, INC. (US) | 2023-03-09 | — | — | WO | disclosed |
| EP-4110368-A1 | TREATMENT OF LIVER FAILURE | Hepyx Limited (GB) | 2023-01-04 | — | — | EP | disclosed |
| EP-4096647-A1 | TREATING ACUTE LIVER DISEASE WITH TLR-MIK INHIBITORS | Yeda Research and Development Co. Ltd (IL) | 2022-12-07 | — | — | EP | disclosed |
| EP-4061409-A1 | STIMULI THAT HYPERACTIVATE RESIDENT DENDRITIC CELLS FOR CANCER IMMUNOTHERAPY | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2022-09-28 | — | — | EP | disclosed |
| US-20130189292-A1 | Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis and related proteins, peptides and compositions | CARDIOVAX, LCC (US) | 2013-07-25 | — | — | US | disclosed |
| WO-2012135550-A1 | BIOMARKER-TARGETING CONTRAST AGENTS AND THEIR USE IN MAGNETIC RESONANCE IMAGING FOR DETECTION OF ATHEROSCLEROTIC PLAQUE | LUNA INNOVATIONS INCORPORATED (US) | 2012-10-04 | — | — | WO | disclosed |
| WO-2012038922-A1 | IMMUNOMODULATORY METHODS AND SYSTEMS FOR TREATMENT AND/OR PREVENTION OF ATHEROSCLEROSIS AND RELATED PROTEINS, PEPTIDES AND COMPOSITIONS | HANSSON GOERAN K (SE) | 2012-03-29 | — | — | WO | disclosed |
| EP-1562624-A4 | ORALLY ADMINISTERED PEPTIDES SYNERGIZE STATIN ACTIVITY | UNIV CALIFORNIA (US) | 2009-07-29 | — | — | EP | disclosed |
| EP-1562624-A2 | ORALLY ADMINISTERED PEPTIDES SYNERGIZE STATIN ACTIVITY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-08-17 | — | — | EP | disclosed |
| WO-2004034977-A2 | ORALLY ADMINISTERED PEPTIDES SYNERGIZE STATIN ACTIVITY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2004-04-29 | — | — | WO | disclosed |
| WO-2002041885-A2 | TREATMENT OF INFLAMMATION AND ASSOCIATED COMPLICATIONS USING PSEUDOHALIDES | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2002-05-30 | — | — | WO | disclosed |
| WO-2001055166-A1 | CLONED HUMAN LYSOPHOSPHOLIPASE | REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2001-08-02 | — | — | WO | disclosed |